{"id":822514,"date":"2025-03-06T08:10:40","date_gmt":"2025-03-06T13:10:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/"},"modified":"2025-03-06T08:10:40","modified_gmt":"2025-03-06T13:10:40","slug":"adagene-to-present-at-leerinks-global-healthcare-conference-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/","title":{"rendered":"Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO and SUZHOU, China, March  06, 2025  (GLOBE NEWSWIRE) &#8212; Adagene Inc. (\u201cAdagene\u201d) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene\u2019s Chairman, Chief Executive Officer and President of R&amp;D, Peter Luo, Ph.D., will participate in one-on-one investor meetings and provide a corporate update at Leerink\u2019s Global Healthcare Conference 2025, taking place March 10-12 in Miami, Florida.<\/p>\n<p>\n        <strong>Leerink\u2019s Global Healthcare Conference 2025<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Presentation Date:<\/strong> Wednesday, March 12<\/li>\n<li>\n          <strong>Presentation Time:<\/strong> 10:40-11:20 AM (Eastern Time)<\/li>\n<li>\n          <strong>Location:<\/strong> W South Beach<\/li>\n<\/ul>\n<p>A webcast of the presentation will be accessible in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=V9bXmFOMuFX6omUygURFOzCVSSWij7kIawFLVCJsM4pH9qH7DvvFt9oQLXIJv4tABB__lq73wVm-yP81bmFEPUmyZCsD24hBeLKY5P6Fphk=\" rel=\"nofollow\" target=\"_blank\">Investors<\/a> section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jGa92gTCjbKzoYYDuWzeA84OvAno6U4ynyT2oj12Ekg6v3pWshPA0qWLT--65QbuygDAME9wZ6vRPAwX2q_8W_LxFBPxl6mEQconPXscXgk=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.adagene.com<\/a> for at least 30 days.<\/p>\n<p>\n        <strong>About\u00a0Adagene<\/strong><br \/>\n        <br \/>Adagene Inc.\u00a0(Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene\u00a0combines computational biology and artificial intelligence to design novel antibodies that address globally unmet patient needs. The company has forged strategic collaborations with reputable global partners that leverage its SAFEbody<sup>\u00ae<\/sup>\u00a0precision masking technology in multiple approaches at the vanguard of science.<\/p>\n<p>Powered by its proprietary\u00a0Dynamic Precision Library\u00a0(DPL) platform, composed of NEObody\u2122, SAFEbody, and POWERbody\u2122 technologies, Adagene\u2019s highly differentiated pipeline features novel immunotherapy programs. The company\u2019s SAFEbody technology is designed to address safety and tolerability challenges associated with many antibody therapeutics by using precision masking technology to shield the binding domain of the biologic therapy. Through activation in the tumor microenvironment, this allows for tumor-specific targeting of antibodies in tumor microenvironment, while minimizing on-target off-tumor toxicity in healthy tissues.<\/p>\n<p>Adagene\u2019s lead clinical program, ADG126 (muzastotug), is a masked, anti-CTLA-4 SAFEbody that targets a unique epitope of CTLA-4 in regulatory T cells (Tregs) in the tumor microenvironment. ADG126 is currently in phase 1b\/2 clinical studies in combination with anti-PD-1 therapy, particularly focused on Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC). Validated by ongoing clinical research, the SAFEbody platform can be applied to a wide variety of antibody-based therapeutic modalities, including Fc empowered antibodies, antibody-drug conjugates, and bi\/multispecific T-cell engagers.<\/p>\n<p>For more information, please visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jGa92gTCjbKzoYYDuWzeAwH8aywZ6gVF7S6KA96zcVQM5KHIPj32Rr7oEUuJHBnali-hDvs8dP2evIy9YX8Ylv6la8XhgxbuJFMUjILc9CEPGAMfUZx-_g1qH4htqPVbE5LQ0mlxRqVgYvltumHGTZnoAARW5qU_L96NPWEl9EX6pz13OOHjd3Qvf2ah34Rh9YW_ngWXahj2Swv9_AUV95gTeUlq_uxz6RvKZuqTGpFNBQtNao03Y00d9T9TZTo65KgyqVuKVda-cUc38ekYuS_VZvIzXFjn9ykSusG-F05Bd1P3hnErBNCV405_yxy18EENIytDMBca2osmSsDkayqOyqcVE0gEcISe3vuDsbQvq3DxqEjnnICh20ZZZiLP7NUEbSqFmmScIlGlsClx2lcbVSlaQmMLPt2lXblJ6WhyMX0pHoy23KYu0U_2JhPUMsSpDBQqVAumBNptE7yr97zv9m-GYum8r1UUNXl6ZuZAPzqWasRs5bk5Plx0XIm8uT2i7WD2-s6wncL1UwvhkUiM5J91BVjoaurf4XTaNe1OthIp2PXxv-hNOZw1b82BO0O7yz_K_oeQyYJOiT-HcinrEXS046p5ZG701_5UzF1eiIs9avVBWzJCYhxsLQ4RY-xwuVbake3DUXZYwIKg79zJrM-A1pUcO_nS9Y7kl4Z0wIWzlwck5IAwGeoSSkWRhmdSXS7aRTYq0aWKJuairzy1fd1QcfQnsOCRj0JYFxyEtNcr1RkEM9amQlYGnVSnNGzoRwdrbzsp7Oepedk0Xm62QoRCvila6hW-fIXx_zKjnpnNLl1I4G1YlVXlEB46o1x9riBp5Lj1GHT6D1WLdakLcxcxb3kXM5dK-Lw8kvdvrm-o9Sbiv7kgJKh_lkJLAquI6y4HHl25RpRQTcD9BHv2TO3zyJ36PJE9vYX3KDKlQ1xRm6tTB6G93o05sYxkfcB4WbsTg7OirW8FET37ANr4puxT9qzKZ3DTZUrOt3vzlReXzQdkm0xPnLt_0aCNJo7P8TMGXLNvaeez0JdDzc6VjM4bbjp9xCjADlrLqC5eHSF8BxolPMyUrVBONqrXdZdk6qs0FM9mrQl0W8bGVjCatZkG-7hGYK_zV9eHHLYmUvsW7kR5yXYNAv56BPBdHhc2a9zjJdvJEFpoMxJSv-exNHPmHc6XwsAOoumh-w7zjMuZbYZT6HgAcFkyaVKS3Clk2GkK3JpXVtwN5Y8_jYwnTXIgnNCmYK99XZ9k91FfKEOI3AwB-P2V4mVPo88sFbhVN00b-u5M4lmK8kcv4QpBbB-HQ9-b-i0t2E_DV7tePf9FMN3iN7DxDPiYaVZTigXIzOgWItk0kqv0S4KKR3QLLbLqOgkfu01i4rsPON2yf8vJGDuZeMDPNr7MB1zLkFgQM1ujtIw1lP4G03Xtyajnhqd9ZcNWCHBE9vXtTRk_D6vGd84ZDyVvw04RKYHKNk7tBEdEAROYCwgoqvhTk_yVEC5pNhgc1dSMVd-8Ge-CQJnu2KqAJav5pwkUBwuxoXziFb3H0mNtWXiuzA9wscy0o6j_VjRbQI7OfhExb4FgsKZj0h-6B0UoGqItjCyBXH8Lzzrs4DXIZMQkGxiCNZ0mw2Z04SR885CLU_nhsfue7uOT1waE4FdU4VzakjsRoo95zRxc-RK7KSqe689R7avuyXxbWZ3yLMdMd4YIe1B4_OmOibsNL4VqljFjJjFoZMX8oJPEvh7jT-Oa-f5LAg==\" rel=\"nofollow\" target=\"_blank\">https:\/\/investor.adagene.com<\/a>.<br \/>Follow\u00a0Adagene\u00a0on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WJlITNgSz7kJDRcNnEGyfusbXgUhW9bR-8tV2cjMARVkJZR2bS0kvFoRjLfB6Xuyz6F1HtZGeylgw3AlQnKR8xQAd4w2V5BNm66A7sVhOc8nL3tQ4ypUi4LijjGs5BZowwpjejY9lzJLrdwCQuBxeqvrs1P25hhLKM6klegLBP5BfOBibUEPobKVZz4N5XjG7hi0__EGPNrFQxkVwSISXIR8wWyNjKwbq1VxKNq9cz_u30d9p7ORna0gQd_uF1G7i2f685Bh28ll1D6rZqPYJicPTtRbDLQS04O0q64bYiaW3Z6uDCbiS96C1O8VY1Rs9V5LcsWu-vmO8ENdyi_FRvMQ6kZqRlFrhLD1BzZb3RoV9KzXWgkPixgkv551y0_UshZw5R0QLz0syqQildxOHaTNpNBWIMhOJh9z1g9sQzTp0RtMcZBMGgQFtvBFJ0FbidyW__spAjuGw8w8LDkFE8G0sTz1fqQDKqw9d750wiXbzk-RwwAG17_iHfkWYvFg2oy_ZEbgUQNA7HVW-NOnyN0G08zgeTg-nk94nw6OaQZe22f9nzlLFIL_MM6nrH2AG50HQXj9VPvOpemrTO4u6W4Pezy8mk10y5cscVCry0O1CEDwW18czFWjNgZKXit0wQKvmn81qr48bHW1fQVps4c62o4t81TSlLqP2ppbbKSn4Ao8aWTpSyFCm7xnUemTfIzA7I_d8TjesV9I47fsh4z61_CxcTXj3oYVKjdNI_GQyNVFoCIPpSAvBxaU-2FxxqU-1EfXR72m1_nunsHYIaiqU8CL49UA6XGWz236G8p049430wHI0wMdACYe0q3DKZOvHa1-M6tLIpBqb-KlcIFxDZVxz5NsAlwatmmBuIANF-hA_3Wr2TbW9xmhWYDP-X8VV1CmAjqWQlaMEpTwYIIIogab6o-XMn4wcbe0kbo22zgOTAOCECOtLipQ_E78sAZ33EvTf1-WSTC6PGhUIw-o4Yua4IbN_kM8TeKeaX64fAVgn5QVfAbGc4-_ppG6FxYhyjLIVGMHsAT5S3MaYhk2noXxaiZyHCNfgZfnlT1PaN3T8LkPmkFBObQhf_wwEj5mq9C3JHL--NUdlQ1GtEW0LE8e09-xZP4qJuAXr2NHmWDaTcY9wWz_V44c9WcQj_lb-InYAny4T17NxmFJXTVaHPQAlpNiIw96LaaLFBz_C4lpbwRHpRZUMVa-okVvrUlxq9UAEQE14dmhKRRRp6HNlnkt4ZIY-sFvhyhbowXtYklEHv3P0E-vxVMJ9BFQ9yp3eBl5nrs2mgWJ_t9P5FN8EEqAb0Pv1l8iw5sJOhdf2NcSWbdchyb_MN8GuNFftafjYABgquE8VzljoWnShiA1LPhBJ0ivtqWu6XJIZMFDCDqtDnn_5y1lVx07qSVqAl8BqLiP6yoh5J0gbWTciIBlo46Oii0QHLx1JgenyMPPIg59HML54yOiN_EpWhySVumJu7-XcYUtItd39GWxnXo0EFTFJiyZ1bUc4rqAV9Y_U3u-Ug8Hne2fVvtpQY6S37BjYr0Pau31MNG7j-a4s43DngD0dBgKuxi3KAukJbhoPduGf0hcRixxNT2vqMV7g99KDo-xIQaVpnOVjxyuY-89vnD5zUIuL-8WKObpnLhEIqn03hYwf6YlVMlNbiFY2ePCGTgxGTPI68RFnEAspf9NFdTqJZPOCO8D8QcMK5qRLP9JFYUyLuAGCUQ-IGBXrCrYGmgJU1KdDISRhz887szpO8AM3Vmxe6lZoi2OxpQUSQWI8kDfpj-va8HVUxPnwoyc2TGRXyiaBqcko0vJyR-FdXGaDNHHJAqQRZgf0xexDhVPy6KNqLxb0gmF4sNNE4XM-6UeoFvlMsMIrjLMctbiLQDPg61pdcn-MjckojE=\" rel=\"nofollow\" target=\"_blank\">WeChat<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yXviMzcyj7uI2aDyThyvAFE9zQ2GWvewHKWWtQrCRDZrc6QvCctwTwIo2rN-5Vukimech0-aCJCSE59kWSopxHUr_3FOVzJcnbAazBqOs8jET23TwAKdjwuCdQf_AjerqO0M_HOuJL6vaM3BV5SWI9QqRq89fACFI53y0_mVloC0olyMLCvn4NioYKOXVbznpoq6WfFhRgDSstlgNYvVTY1gnQj16T6xoss3qvzbfCP6nP9zw4hHfE420kY3955VoMBBSHC8PMS04hxTqNe82JLMW1nGPFZ1Vau0LaGLZ2btzVrGoJ1rZH51TE_F5B1L1cqin9RKYgRRCE28sgyqFNVqSEs3niWJwfQIgNhB_IGqxurGniwP7A6HR0PVL_C6U17hYfHBSg6bsLj-WHuKGwocV0uTCm7mZJqyxu_GL67l0usnwszYewAsrhI8ilQzhvyJ3CeDIA4M777w5hPuJFoWekI-jJ-m5_5NUnO1aEZhkn4Fy7ghxJ-QPi8Idbc-uTrgTPLGvXZ6fR4XF3OlTwX8ufEofGviF6LTWp8pCEai3p78PuYUWr0gGxi0NhFSvAuFjnaVME4ef4iqdoY7n0KmGDvE1m-oCsYKK3xIGpXF3T069VLgNfLHwXj1KIIcQdwuLNtLM8uVv17DBi-4v-q6-vJo1OxUoCSOPclk5sx9MWFpOFepoSmjBiKb7Bu3pawdmqjfgA_s-_Y1nLUkVBEeYj9JJi38VHrz-je0lP8J4V2rtQazARZEtMGfTNXuL_-4C1LiZLTLt8gRDAb4pENy_UJMJKMbcHwjeS0tRx_cDfMVTnpQQJympwc85KxPyAnagWCdw4sSGy9JAXuuuiGIsIFdLk8lTG6a_7eYPPPVDEHsuZmhsEHHF7eiRmw5jY5mkoJ_T6J6FdZmYomvha5Yuac3dIoer2xPycIKMP2xffvKKA2fs1wYT5l6-Zgi-FZJItTae9B-w2Z8FWFkj3Oo7pcIOvl-SZdOrWbT8qgR9lU73X8MhDS7F_QCHPTDSBSunAhgr8OU8CNDk-PMBw==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wv3jC1I_GOIOlqZgZUpgyGQjAIaMiWCzD3slzk3bivo21uNrRQT0JSkanLtGzwphuBLWzaYw9SY71HoNDIMxVyF6LO4mU5YLtmAT-ePkAlNb20qHoXid6HLdvqtnTVDRjO9UUQpz3BqkMgx57YZxFWzqWQ_kj36_pe6gdbW9ziXFTkGlDSenmLIkK531nTK3is-AwhT2CDI6wdyR5qYRUTdBWW56E6grPxwEcSW1o1eJgDdqosVZZjj3gn9s_AcQPXP6B2EM9MgPJnu3Qk_bbZHWphHZ4FMehQyQVizYS862hBVqM_MGhbbYNXCObSxONG8tWU90JCV3a13c7mGzUubiXvXrFs-TfbD7iAGEuQF5gkAm8MCH5_41NIVvPF-siPvYDscm6ZxlGlq-EK31WVXYqANb_AWfoEnJzIX6k4g72AmL9q6mRPMV98s7fZOLJi5PPt0ylZBEVmhV4iNk3ZOBgrbu7sZqcwrKtRjflZ4LLARi4DpXMOlfNd0J0OlZNAQn7b2NLOnLnwU-AbHm0mYJ9As8Gd9iQOQJ2fVOVSGyLtEgQav3VtubDRGnxMCKSmzUjFgOB7nisVAu9jrRVTQmJtm6XfPZA8zz4Ezmy0WLEc7geAvjNrjMcz13jPOwra4aJhjMNDZTN9u_mtADntKU6IKdLdQw55jNIWdwX8vagb23ZjG7cFzhBCtIo0dP6MgGLwT58__T88x4aUuyPKP5yPwuV7aywMIhcQi6krPwtWTvZhuHZqRYRZxRXdXiecy-BHgDlZ5Zx92qiS1hcIGJL_2WXJSjoU3ObQyKX4ybBohNG6twecmd7nb16niIs1r1vog7eknx69SCEl6bMZ4VCdRfCrWIQxCH6E0msGVVGNhorWhAXb2duDgxDJkT80GMntaeJOEEZCrMV22spH00t83SFPPW3LwhLfpN0j4aYUycPCnqd5tPCTTibbJsH0uO-5_sTp2VOZh68Ri6r2gk9z1kMYpKBKGGeN-cfV4YyMQ97kRIx-sc6pAp18S6\" rel=\"nofollow\" target=\"_blank\">Twitter<\/a>.<\/p>\n<p>SAFEbody<sup>\u00ae<\/sup>\u00a0is a registered trademark in\u00a0the United States, China, Australia, Japan, Singapore, and the European Union.<\/p>\n<p>\n        <strong>Investor Contacts:<\/strong>\n      <\/p>\n<p>Raymond Tam<br \/>Adagene<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XrYyxaT-Pt81LcVFoTWHVp93AIYFLW3YpRsoZzh9K7VUg8zLwZAmidosrrTcuT-S7GoFai5HfzDxmMQ5PRT8KfZ3Dy4UdT6mPTWN4KvIPbc=\" rel=\"nofollow\" target=\"_blank\">raymond_tam@adagene.com<\/a><\/p>\n<p>Bruce Mackle<br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RSWWGeYq95CQfo1AK3kvYPzg65veMhGcavLnTq1yLkPysQDr1UoS3HIqbudwGXrtkg1z-tqpRWtLD3OmImOV8_au439RT_bfU6cctP2uMtuYSsXT9uLUqJa3pOH5oCUy\" rel=\"nofollow\" target=\"_blank\">bmackle@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTk3MCM2NzkzMzg0IzIyMDQ2ODE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjU4NDg1M2UtZWMxNi00ZGI1LTkxMTQtNWVjOTczMDE2MTU1LTEyMTYyMzQ=\/tiny\/Adagene-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO and SUZHOU, China, March 06, 2025 (GLOBE NEWSWIRE) &#8212; Adagene Inc. (\u201cAdagene\u201d) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene\u2019s Chairman, Chief Executive Officer and President of R&amp;D, Peter Luo, Ph.D., will participate in one-on-one investor meetings and provide a corporate update at Leerink\u2019s Global Healthcare Conference 2025, taking place March 10-12 in Miami, Florida. Leerink\u2019s Global Healthcare Conference 2025 Presentation Date: Wednesday, March 12 Presentation Time: 10:40-11:20 AM (Eastern Time) Location: W South Beach A webcast of the presentation will be accessible in the Investors section of the company\u2019s website at https:\/\/www.adagene.com for at least 30 days. About\u00a0Adagene Adagene Inc.\u00a0(Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company committed &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-822514","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO and SUZHOU, China, March 06, 2025 (GLOBE NEWSWIRE) &#8212; Adagene Inc. (\u201cAdagene\u201d) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene\u2019s Chairman, Chief Executive Officer and President of R&amp;D, Peter Luo, Ph.D., will participate in one-on-one investor meetings and provide a corporate update at Leerink\u2019s Global Healthcare Conference 2025, taking place March 10-12 in Miami, Florida. Leerink\u2019s Global Healthcare Conference 2025 Presentation Date: Wednesday, March 12 Presentation Time: 10:40-11:20 AM (Eastern Time) Location: W South Beach A webcast of the presentation will be accessible in the Investors section of the company\u2019s website at https:\/\/www.adagene.com for at least 30 days. About\u00a0Adagene Adagene Inc.\u00a0(Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company committed &hellip; Continue reading &quot;Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-06T13:10:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTk3MCM2NzkzMzg0IzIyMDQ2ODE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025\",\"datePublished\":\"2025-03-06T13:10:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\\\/\"},\"wordCount\":396,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4OTk3MCM2NzkzMzg0IzIyMDQ2ODE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\\\/\",\"name\":\"Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4OTk3MCM2NzkzMzg0IzIyMDQ2ODE=\",\"datePublished\":\"2025-03-06T13:10:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4OTk3MCM2NzkzMzg0IzIyMDQ2ODE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4OTk3MCM2NzkzMzg0IzIyMDQ2ODE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/","og_locale":"en_US","og_type":"article","og_title":"Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025 - Market Newsdesk","og_description":"SAN DIEGO and SUZHOU, China, March 06, 2025 (GLOBE NEWSWIRE) &#8212; Adagene Inc. (\u201cAdagene\u201d) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene\u2019s Chairman, Chief Executive Officer and President of R&amp;D, Peter Luo, Ph.D., will participate in one-on-one investor meetings and provide a corporate update at Leerink\u2019s Global Healthcare Conference 2025, taking place March 10-12 in Miami, Florida. Leerink\u2019s Global Healthcare Conference 2025 Presentation Date: Wednesday, March 12 Presentation Time: 10:40-11:20 AM (Eastern Time) Location: W South Beach A webcast of the presentation will be accessible in the Investors section of the company\u2019s website at https:\/\/www.adagene.com for at least 30 days. About\u00a0Adagene Adagene Inc.\u00a0(Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company committed &hellip; Continue reading \"Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-06T13:10:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTk3MCM2NzkzMzg0IzIyMDQ2ODE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025","datePublished":"2025-03-06T13:10:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/"},"wordCount":396,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTk3MCM2NzkzMzg0IzIyMDQ2ODE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/","name":"Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTk3MCM2NzkzMzg0IzIyMDQ2ODE=","datePublished":"2025-03-06T13:10:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTk3MCM2NzkzMzg0IzIyMDQ2ODE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4OTk3MCM2NzkzMzg0IzIyMDQ2ODE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-leerinks-global-healthcare-conference-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Adagene to Present at Leerink\u2019s Global Healthcare Conference 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/822514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=822514"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/822514\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=822514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=822514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=822514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}